3D tool provides images of DNA sequences, cancer cells

A new computer tool able to produce 3D images of genes, proteins and metabolites may help scientists better understand cell mutations that cause disease which can ultimately influence drug development theories to treat cancer and other diseases.

According to an article published Feb. 28 by Clinical Innovation and Technology, the Recon3D works with the elaborate structure of DNA's coils, twists and folds in a linear fashion to integrate 3,288 open reading frames (stretches of DNA and RNA that contain protein-producing genes), 13,542 metabolic reaction and 3D structures of 4,140 metabolites and 12,890 proteins

With the Recon3D, researchers at the University of California, San Diego (UCSD) were able to pinpoint harmful and potentially cancerous genetic mutations, many of which located adjacent to one another. 

"This is the first resource to link all these different data types together in one place and has shown to be a very valuable tool for analyzing sequencing data," said lead author Elizabeth Brunk, a postdoctoral researcher at UCSD.

The study, published online last week in Nature Biotechnology, was led by Bernhard Palsson, PhD, a professor of bioengineering at UCSD. 

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.